TARDBP and frontotemporal dementia: TMEM106B was first identified as a risk-associated gene for FTD with TDP-43 pathology (FTLD-TDP) and since then has been recognized as an important modifier of disease risk in a variety of neurodegenerative disorders [reviewed in (5, 6)].